Published: September 2016
Report Code: LS10735
Category : Healthcare
Adhesion barrier is a physical barrier that is applied between layers of tissue during surgical procedures to keep them separated from other tissues and organs. Adhesion barrier is available in market in the form of film, gel and liquid/solution formulations. During the healing process, the adhesion barrier dissolves and is absorbed by the body after a few days of surgery. Ideal adhesion barrier products are non-toxic, biodegradable, non-allergic and easy to utilize during the surgical procedures. They are commonly used in various surgical procedures, including neurological surgeries, cardiovascular surgeries, gynecological surgeries and orthopedic surgeries. These adhesion barrier products are placed at or near the surgical site. When the tissue is healed, there is no longer a danger of adhesion formation. Adhesion barrier products provide many benefits including safety, absorbability, and fast application on injured tissues.
Based on type of product, the global adhesion barrier market is segmented into synthetic adhesion barrier and natural adhesion barrier. Synthetic adhesion barrier, which includes hyaluronic acid, regenerated cellulose and poly ethylene glycol (PEG), held the larger share in the global adhesion barrier market in 2015. Synthetic adhesion barrier products are used to prevent intra-abdominal adhesions in intra-abdominal sepsis. These barriers are absorbable, flexible, and adhere easily to tissues. For instance, Seprafilm adhesion barrier comprises sterile, bioresorbable, translucent membrane sodium hyaluronate(HA) and carboxymethylcellulose (CMC). Natural adhesion barrier includes collagen & protein based, and fibrin based adhesion barrier. Natural adhesion barrier products are procoagulant and can induce fibrin deposition in the presence of blood within the peritoneal cavity.
Film formulation was the majorly used product form in the global adhesion barrier market in 2015, and it is also the form which is expected to witness the highest growth during 2016 - 2022. Film formulation includes a mesh-like/thin sheet designed to be placed over or in-between the injured surfaces. These are commonly used in laparoscopic surgeries.
In 2015, North America was the largest market for adhesion barriers due to increasing volume of surgeries, improved healthcare infrastructure, and growing geriatric population. The U.S. was the largest contributor to the North American adhesion barrier market. According to the Agency for Healthcare Research and Quality, in the U.S., the largest number of surgical procedure were of arthroplasty knee, which stood at 700,100 in 2012. Also, the number of percutaneous coronary angioplasty (PTCA) surgical procedure in the U.S. was 534,600 in 2012.
The global adhesion barrier market was valued at $761.0 million in 2015 and it is expected to grow at a CAGR of 8.5% during 2016 – 2022. Increase in volume of surgeries, increase in sports related injuries and growing geriatric population are the major factors driving the growth of the global adhesion barrier market. However, the high cost of adhesion barrier products acts as a barrier for the growth of the global adhesion barrier market.
The global adhesion barrier market is growing due to increase in the volume of surgeries and growing geriatric population across the globe. According to the World Health Organization (WHO), around 234.2 million surgical procedures are performed every year, worldwide. The rising awareness among patients about better healthcare products is also supporting the growth of global adhesion barrier market. An adhesion during surgery may lead to bowel obstruction, chronic pain and dysfunction of organs. Surgical interventions are commonly used for the treatment of adhesions, which further deteriorates the patients’ medical condition. As a result, demand for adhesion barrier products is increasing to prevent complications during surgeries.
Growing geriatric population is one of the major factors driving growth of the global adhesion barrier market. As per a report by the United Nations Department of Economic and Social Affairs on the global aging population, the number of people aged 60 years or over is projected to grow by 56%, globally, i.e. from 901 million in 2015 to 1.4 billion in 2030. It further reported that the global geriatric population is projected to reach nearly 2.1 billion by 2050. Elderly people are more susceptible to diseases requiring surgical interventions for their treatment, leading to greater demand for adhesion barrier products. In addition, increase in number of sport-related injuries further increases the demand for adhesion barriers thus, driving the growth of market globally. The increasing worldwide healthcare expenditure is leading to the improved healthcare infrastructure and consequently hospitals are able to include better medical facilities as a part of treatment to alleviate patient’s medical condition.
Sanofi held the largest share in the global adhesion barrier market in 2015. The top 6 players in the adhesion barrier market including Sanofi, Johnson & Johnson, Baxter International Inc., Medtronic Plc., Getinge AB, and C. R. Bard. together account for more than 60% of the global market. Other key players in the market include Integra LifeSciences Holdings Corporation, Anika Therapeutics Inc., FzioMed, Inc. and MAST Biosurgery AG.
P&S Market Research offers customization as per specific business requirements of clients. Illustrative customization within the scope of this report includes: